Suchergebnisse - "Fulgenzi, Claudia A. M."

PubPharm (28)

1

The Hammersmith Score optimises patient selection and predicts for overall survival in early-phase cancer trial participants independent of tumour burden

enthalten in: Chemotherapy | 2024

von Korolewicz, J. | Scheiner, B. | Fulgenzi, C. | +22

2

Immunotherapy at all stages of hepatocellular carcinoma

enthalten in: Nature medicine | 2024

von Pinato, D. | Fulgenzi, C. | D'Alessio, A.

3

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

enthalten in: Journal of hepatology | 2024

von Celsa, C. | Cabibbo, G. | Fulgenzi, C. | +69

4

Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma : an analysis from the OnCovid registry

enthalten in: Therapeutic advances in medical oncology | 2024

von Vincenzi, B. | Cortellini, A. | Mazzocca, A. | +36

5

Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy : A global, observational study

enthalten in: Hepatology communications | 2023

von Joerg, V. | Scheiner, B. | D Alessio, A. | +33

6

The price and value of therapeutic synergy in liver cancer

enthalten in: Lancet (London, England) | 2023

von Pinato, D. | D'Alessio, A. | Celsa, C. | +2

CommentOn: Lancet. 2023 Sep 30;402(10408):1133-1146. - PMID 37499670

7

Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

enthalten in: JHEP reports : innovation in hepatology | 2023

von Pinato, D. | Kaneko, T. | D'Alessio, A. | +21

8

Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma

enthalten in: JHEP reports : innovation in hepatology | 2023

von Pinato, D. | Li, X. | Mishra-Kalyani, P. | +14

9

Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Alessi, J. | Elkrief, A. | Ricciuti, B. | +25

CommentIn: J Thorac Oncol. 2023 Jun;18(6):682-685. - PMID 37210177

10

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer : results from the OnCovid registry

enthalten in: The Lancet. Oncology | 2023

von Cortellini, A. | Tabernero, J. | Mukherjee, U. | +126